Palantir will report its second-quarter earnings after the closing bell on Aug. 4.There are probably few investors out there who are more satisfied than those who bought Palantir Technologies (PLTR -2.46%) stock early in its run. The artificial intelligence (AI) company is blowing other stocks out of the water these days, with its stock up 478% in the last year and more than doubling in 2025. Palantir is now one of the world's top 25 most valuable companies, ahead of such blue chip names as Procter & Gamble ...

Ryan Specialty (RYAN -5.46%), a leading provider of specialty insurance solutions, reported its second quarter 2025 results on July 31, 2025. The company posted GAAP revenue of $855.2 million, surpassing analyst expectations of $832.0 million, and adjusted diluted earnings per share (non-GAAP) of $0.66, a slight beat over the $0.65 consensus. Organic revenue growth rate (non-GAAP) was 7.1%, down from 14.2% in Q2 2024, coming in below company guidance for full year 2025 of 9.0%–11.0% and below historical tre ...

Grid Dynamics (GDYN -16.44%), a digital engineering and consulting firm, reported its second quarter fiscal 2025 earnings on July 31, 2025. The main news was a GAAP revenue increase to $101.1 million compared to Q2 2024, beating analyst expectations of $100.72 million and slightly exceeding its own midpoint guidance. Non-GAAP earnings per share came in at $0.10, topping the consensus estimate by $0.01. Operating results showed rapid growth in AI and Finance services, with the AI and Data practice accounting ...

Can the EV maker follow its uphill path to profitability? Shares of Lucid Group (LCID -1.02%) are trading lower this week, down 17.1% as of 3:37 p.m. ET on Friday. The drop comes as the S&P 500 lost 2.4%, and the Nasdaq-100 lost 2.2%. Lucid has a long way to go Lucid has announced plans to initiate a reverse stock split, a move often reserved for companies in danger of delisting from the Nasdaq or NYSE. Its stock is also taking a hit from today's larger macro news. Lucid is at a critical juncture. It must g ...

Agios Pharmaceuticals (AGIO -5.96%), a biotechnology company focused on therapies for rare blood disorders, released its second quarter 2025 earnings on July 31, 2025. The headline was a notable revenue beat: This quarter showcased clear progress on sales for its lead product PYRUKYND, with GAAP net product revenue of $12.5 million, yet also highlighted the company's increasing cost base as it prepares for major regulatory events and launches. Overall, the quarter delivered strong revenue momentum, but at t ...

F & M Bank (FMBM 3.08%), a Virginia-based community bank with a focus on traditional and relationship- driven banking services, reported its second-quarter 2025 earnings results on July 30, 2025. The headline news from the release centered around a significant expansion in net interest margin (GAAP), improvement in tangible book value per share (non-GAAP), and a sustained quarterly dividend. Earnings per share were $0.84, slightly below $0.86 for the same period in 2024, even as core profitability metrics a ...

Opko Health (OPK -7.42%), a diversified healthcare company operating in diagnostics and pharmaceuticals, released its second quarter 2025 results on July 31, 2025. The company reported a significant revenue miss, with total GAAP revenue at $156.8 million, compared to analyst expectations of $165.7 million for Q2 2025. Its net loss per share on a GAAP basis reached $0.19, wider than estimates for a $0.11 loss and sharply higher than the prior-year figure in Q2 2025. Results were affected by lower diagnostics ...

American Homes 4 Rent (AMH 1.47%), a major single-family home rental real estate investment trust, reported its financial results on July 31, 2025. The headline news was a strong beat on both earnings (non-GAAP) and revenue (GAAP): Core funds from operations (Core FFO) per share and unit came in at $0.47, ahead of the $0.17 analyst estimate (Non-GAAP). Revenue (GAAP) reached $457.5 million, beating the expected $450.2 million (GAAP). Core NOI from Same-Home properties increased 4.1% and revenue increased 8. ...

Cvr Partners (UAN 1.00%), a U.S.-based nitrogen fertilizer producer, reported sharply higher profitability and revenue for Q2 2025, released on July 30, 2025. The quarter covered the three months ending June 30, 2025. Net sales (GAAP) reached $168.6 million, climbing 26.9% compared to the second quarter of 2024, while earnings per common unit (GAAP) rose to $3.67. These results do not have analyst estimates for comparison, but both revenue and earnings (GAAP) improved significantly from last year’s quarter, ...

The next-generation diagnostics specialist had a beat-and-raise second quarter.Friday's stock market was generally a gloomy place, but apparently someone forgot to tell Fulgent Genetics (FLGT 7.80%). The company's shares were soaring in late-session action, with a very healthy rise of more than 8%. At that point, the bellwether S&P 500 index was mired in a funk with a nearly 2% decline. Fulgent's latest earnings release was a major reason for this dichotomy.A surprise on the bottom lineThat morning, before ...